ImmunityBio has surged over 200% YTD, yet I see little fundamental justification for its current $10B enterprise value. Click here to read why IBRX is a Sell.

Reddit is upgraded to a buy, driven by strong AI licensing revenue and robust growth, though valuation remains rich. Learn ...

ABI and scripting to the Wasm Component Model (WASI Preview 2). He shares how to build secure plugin systems that run at near ...

The City of Toronto is in the midst of vetting software firms that can provide a service to partly automate the prescreening ...

Google ships WebMCP protocol, letting websites expose structured functions to AI agents and reducing computational overhead ...

Four serious new vulnerabilities affect Microsoft Visual Studio Code, Cursor and Windsurf extensions, three of which remain ...

At this event held at Bharat Mandapam, the government, companies, and startups highlighted that AI is now opening up the ...